Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Mid...
Illumina Inc. Stock Outperforms Competitors On Strong Trading Day
The Bull Case For Eli Lilly (LLY) Could Change Following Its Deeper Role In Illumina’s Billion Cell Atlas
BlackRock Inc. Stock Underperforms Monday When Compared To Competitors
Cathie Wood Dumps $39 Million Worth of AMD Stock
Illumina (NASDAQ:ILMN) Stock Rating Lowered by Wall Street Zen
Illumina expands Billion Cell Atlas program with new AI drug developers | ILMN Stock News